Global Ocular Implants Market-Projected to Reach $23.43 Billion by 2031
|
Meticulous Research®, a leading global market research company, has
released its latest report titled "Ocular
Implants Market Size, Share, Forecast, & Trends Analysis by Type
(Scleral, Stock, Orbital, Intraocular, Retinal, Corneal), Material (Silicone,
Hydroxyapatite), Application (Prosthesis, Oculoplasty, Glaucoma Surgery), End
User - Global Forecast to 2031."
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5928
According
to the new report, the global ocular implants market is poised to reach $23.43
billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% from
2024 to 2031. This robust growth is driven by an aging global population,
increasing prevalence of eye diseases, the rise in minimally invasive surgical
procedures, advancements in ocular implant technology, and escalating
healthcare expenditures. Additionally, the surge in accident-related eye
injuries further fuels the demand for ocular implants. However, market growth
is tempered by challenges such as post-surgery complications, a shortage of
skilled ophthalmic surgeons, stringent regulatory requirements, and high costs
of implants.
Key
Market Trends and Innovations
The
ocular implants market is witnessing significant advancements and trends,
including the development of biomaterial-based ocular implants, AI-driven
3D-printed prosthetic eyes, and drug-eluting implants. These innovations are
expected to provide substantial growth opportunities for market participants.
Key
Market Players
Leading
companies in the ocular implants market include:
- Alcon Inc.
(Switzerland)
- Bausch + Lomb
Corporation (Canada)
- Carl Zeiss AG
(Germany)
- Johnson & Johnson
Vision Care, Inc. (U.S.)
- STAAR Surgical
Company (U.S.)
- Morcher GmbH
(Germany)
- HOYA Corporation
(Japan)
- Glaukos Corporation
(U.S.)
- AbbVie Inc. (U.S.)
- Vivani Medical Inc.
(U.S.)
Market
Segmentation and Future Outlook
The
report segments the ocular implants market by type, material, application, end
user, and geography.
- Type:
The market is bifurcated into non-functional implants (e.g., scleral
shells, stock shells, custom-made prostheses) and functional implants
(e.g., intraocular lenses, glaucoma implants, retinal implants, corneal
implants). In 2024, the functional implant segment is expected to
dominate the market, driven by a growing elderly population and
increasing adoption of minimally invasive eye surgeries.
- Material:
The market is divided into inert materials (e.g., glass, silicone, methyl
methacrylate) and biointegrated materials (e.g., hydroxyapatite, porous
polyethylene, aluminum oxide). Inert materials are anticipated to hold
the largest market share in 2024 due to their cost-effectiveness and high
compatibility.
- Application:
Key applications include ocular prosthesis, glaucoma surgery,
oculoplasty, and drug delivery. Glaucoma surgery is projected to account
for the largest share of the market in 2024, supported by the rising
incidence of glaucoma and enhanced accessibility to ocular implants.
- End User:
The market is categorized into hospitals, ophthalmic clinics, ambulatory
surgery centers (ASCs), and other end users. Hospitals are expected to be
the predominant end user segment in 2024, owing to their advanced medical
facilities and a growing number of patients preferring hospital-based
treatments.
Quick Buy
@ https://www.meticulousresearch.com/Checkout/42330084
Geographical
Insights
- North America:
Expected to hold the largest market share in 2024, driven by a high
incidence of eye disorders, established presence of key market players,
and advanced healthcare infrastructure.
- Asia-Pacific:
Forecasted to register the highest CAGR during the projection period,
fueled by an increasing number of diabetic patients, rising geriatric
population, and significant investments in healthcare infrastructure by
regional governments.
About Meticulous Research®
Meticulous Research® was founded in 2010
and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private
limited company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market intelligence in
North America, Europe, Asia-Pacific, Latin America, and the Middle East &
Africa.
The name of our company defines our
services, strengths, and values. Since the inception, we have only thrived to
research, analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research techniques, we
have built strong capabilities in data collection, interpretation, and
analysis of data including qualitative and quantitative research with the
finest team of analysts. We design our meticulously analyzed intelligent and
value-driven syndicate market research reports, custom studies, quick
turnaround research, and consulting solutions to address business challenges
of sustainable growth.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment